Tag: Biotechnology
Advancing GIST Drug: IDRx Secures $120 Million Funding
IDRx, a precision oncology company based in the US, recently announced the successful completion of a $120 million series B preferred stock financing round....
Intellia Therapeutics Q2 2024 Earnings & Company Updates Conference Call
Intellia Therapeutics, Inc., based in CAMBRIDGE, Mass., recently announced that they will be hosting a conference call on August 8, 2024, at 8 a.m....
Senseonics Q2 Results Disappoint, But 365-Day CGM Progress Remains Strong
Senseonics, a company specializing in long-term implantable continuous glucose monitoring (CGM) systems, experienced a slight setback in their second-quarter results, causing their shares to...